首页> 外文期刊>Lung >Differential Diagnosis of Tuberculous and Malignant Pleural Effusions: What is the Role of Adenosine Deaminase?
【24h】

Differential Diagnosis of Tuberculous and Malignant Pleural Effusions: What is the Role of Adenosine Deaminase?

机译:结核性和恶性胸腔积液的鉴别诊断:腺苷脱氨酶的作用是什么?

获取原文
获取原文并翻译 | 示例
       

摘要

The objective of this study was to evaluate the utility of invasive and noninvasive diagnostic procedures in tuberculous pleurisy (TPE) in an area with intermediate incidence of tuberculosis. The aim was to determine the cutoff value for adenosine deaminase (ADA) and the sensitivity and specificity of ADA and evaluate pleural fluid cytology and pleural biopsy in the differential diagnosis of malignant and tuberculous pleurisy. The study included 121 patients. TPE was confirmed in 54 patients and malignant effusion in 67 patients. Criteria used for TPE diagnosis were positive cultures of effusion or biopsy specimen, tuberculous granulomas, or positive sputum cultures without other explanation for pleural effusion. Malignancy was diagnosed by either cytology or biopsy. The cutoff value of ADA in TPE was 49 U/L, sensitivity was 89.2%, specificity was 70.4%, positive predictive value (PPV) was 84.4%, and negative predictive value (NPV) was 78.4%. ADA activity below 16 U/L suggests that TPE is highly unlikely with sensitivity = 38.5%, specificity = 100%, PPV = 100%, and NPV = 57.4%. ADA effusion/serum ratio reached a cutoff in TPE of 1.7 (sensitivity = 84.6%, specificity = 72.2%, PPV = 81.4%, NPV = 71.4%). Sensitivity, specificity, PPV, and NPV of cytology evaluation for TPE are 72.2%, 70.1%, 66.1%, and 75.8%, respectively. Pleuroscopy-guided pleural biopsy had sensitivity = 66.7%, specificity = 100%, PPV = 100%, and NPV = 78.8%. In 27.8% of TPE cases, pleural fluid cultures were positive. There is no doubt that pleuroscopy-guided biopsy is of great value for TPE diagnosis; however, sensitivity and specificity of noninvasive tests, especially ADA, can help to distinguish between TB and malignancy.
机译:这项研究的目的是评估结核性胸膜炎(TPE)在结核病中等发病地区的侵入性和非侵入性诊断程序的实用性。目的是确定腺苷脱氨酶(ADA)的临界值以及ADA的敏感性和特异性,并评估胸膜细胞学和胸膜活检在恶性和结核性胸膜炎的鉴别诊断中的价值。该研究包括121名患者。 54例患者中确诊为TPE,67例患者中为恶性积液。 TPE诊断的标准是积液或活检标本的阳性培养物,结核性肉芽肿或痰培养阳性,而胸膜积液没有其他解释。通过细胞学或活检诊断为恶性肿瘤。 TPE中ADA的临界值为49 U / L,敏感性为89.2%,特异性为70.4%,阳性预测值(PPV)为84.4%,阴性预测值(NPV)为78.4%。低于16 U / L的ADA活性表明TPE的可能性极小,灵敏度= 38.5%,特异性= 100%,PPV = 100%,NPV = 57.4%。 ADA积液/血清比率在TPE中达到1.7的临界值(敏感性= 84.6%,特异性= 72.2%,PPV = 81.4%,NPV = 71.4%)。 TPE细胞学评估的敏感性,特异性,PPV和NPV分别为72.2%,70.1%,66.1%和75.8%。腹腔镜检查指导的胸膜活检的敏感性= 66.7%,特异性= 100%,PPV = 100%,NPV = 78.8%。在27.8%的TPE病例中,胸水培养阳性。毫无疑问,胸膜镜引导下的活检对TPE诊断具有重要的价值。但是,非侵入性检查(尤其是ADA)的敏感性和特异性可以帮助区分结核病和恶性肿瘤。

著录项

  • 来源
    《Lung》 |2008年第4期|233-240|共8页
  • 作者单位

    Department for Interventional Pulmonology Medical Faculty Clinic for Pulmonary Oncology Institute for Pulmonary Diseases of Vojvodina University of Novi Sad Institutski put 4 Sremska Kamenica 21204 Serbia;

    Medical Faculty Clinic for Tuberculosis and Granulomatous Diseases Institute for Pulmonary Diseases of Vojvodina University of Novi Sad Sremska Kamenica Serbia;

    Medical Faculty Clinic for Thoracic Surgery Institute for Pulmonary Diseases of Vojvodina University of Novi Sad Sremska Kamenica Serbia;

    Ludwig Boltzmann Institute for Rheumatology and Balneology Vienna Austria;

    Department for Interventional Pulmonology Medical Faculty Clinic for Pulmonary Oncology Institute for Pulmonary Diseases of Vojvodina University of Novi Sad Institutski put 4 Sremska Kamenica 21204 Serbia;

    Department for Interventional Pulmonology Medical Faculty Clinic for Pulmonary Oncology Institute for Pulmonary Diseases of Vojvodina University of Novi Sad Institutski put 4 Sremska Kamenica 21204 Serbia;

    Medical Faculty Clinic for Tuberculosis and Granulomatous Diseases Institute for Pulmonary Diseases of Vojvodina University of Novi Sad Sremska Kamenica Serbia;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Adenosine deaminase; Lung cancer; Malignant pleural effusion; Pleural biopsy; Tuberculous pleural effusion;

    机译:腺苷脱氨酶;肺癌;恶性胸腔积液;胸膜活检;结核性胸腔积液;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号